Takeda Pharmaceutical Company Limited;Robert Evans;Eric Fedyk;Lin Zhao;Martin Dahl
发明人:
DAHL, Martin,FEDYK, Eric,EVANS, Robert,ZHAO, Lin
申请号：
AU2019208102
公开号：
AU2019208102A1
申请日:
2019.01.14
申请国别(地区):
AU
年份:
2020
代理人:
摘要：
Methods of administering isolated anti-CD38 antibodies at low dosages subcutaneously are disclosed. The methods provide an effective treatment for autoimmune diseases and cancers, including hematologic diseases. Also disclosed are unit dosage forms for the anti-CD38 antibodies.
